← Back to Patent Explorer
US3917824A Expired / Lapsed US ⏱️ 0.0 years remaining

Pharmaceutical compositions containing epidermal growth factor or closely related derivatives thereof for inhibiting the secretion of acidic gastric juice in warm blooded animals

Assignee: Imperial Chemical Industries Ltd
•
Filing: 1974-02-19
•
Granted: 1975-11-04
•
Expires: 1994-02-19
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The use of Epidermal Growth Factor, a known polypeptide, and closely related derivatives for inhibiting the secretion of acidic gastric juice in warm blooded animals, and pharmaceutical compositions enabling this use to be carried out.

Inventors

  • 👤 Roger Camble
  • 👤 Harold Gregory
  • 👤 Ernest Edward Lawrence Gerring

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 19:13
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/475; C07K14/485; A; A61; A61K; A61K38/00; Y; Y10; Y10S; Y10S930/00; Y10S930/01; Y10S930/12

Claims Analysis

Total Claims: 3
Claim 1
Independent Claim 64 words
A METHOD OF INHIBITING THE SECRETION OF ACIDIC GASTRIC JUICE IN WARM BLOODED ANIMALS WHICH REQUIRE SUCH TREATMENT, WHICH COMPRISES ADMINISTERING BY INJECTION TO THE WARM BLOODED ANIMAL A THERAPEUTICALLY EFFECTIVE AMOUNT OF EGF, 1-47 EGF, 1-48 EGF OR 1-51 EGF, OR A REDUCTION AMOUNT OF EGF, EGF, 1-47 EGF, 1-48 EGF OR 1-51 EGF IN WHICH THE CYSTINE RESIDUES ARE REDUCED TO CYSTEINE.
Claim 2
Independent Claim 64 words
A METHOD OF INHIBITING THE SECRETION OF ACIDIC GASTRIC JUICE IN WARM BLOODED ANIMALS WHICH REQUIRE SUCH TREATMENT, WHICH COMPRISES ADMINISTERING BY INJECTION TO THE WARM BLOODED ANIMAL A THERAPEUTICALLY EFFECTIVE AMOUNT OF EGF, 1-47 EGF, 1-48 EGF OR 1-51 EGF, OR A REDUCTION AMOUNT OF EGF, EGF, 1-47 EGF, 1-48 EGF OR 1-51 EGF IN WHICH THE CYSTINE RESIDUES ARE REDUCED TO CYSTEINE.
Claim 3
Dependent Claim 27 words
A method as claimed in claim 1 wherein a dose of from 0.1 to 10 Mu g./kg. of active ingredient is administered by intravenous or subcutaneous injection.

References Cited (Backward Citations)

US3549610A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1978-11-03 1979-05-05 1979-11-04 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1982-11-03 1983-05-05 1983-11-04 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1986-11-03 1987-05-05 1987-11-04 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag